|
CN110638801A
|
|
Injection medicine and preparation method thereof
|
|
CN112225732A
|
|
Novel perospirone hydrochloride hydrate crystal form and preparation method thereof
|
|
CN111377836A
|
|
Crystal form of ecabet sodium and preparation method thereof
|
|
CN111362824A
|
|
Process for the preparation of 2- (aminomethyl) -N, N-diethyl-1-phenylcyclopropanecarboxamide and salts thereof
|
|
CN111349003A
|
|
Preparation method of sodium valproate
|
|
CN110563715A
|
|
Process for preparing imidazoline-diazacyclopentene derivatives
|
|
CN109975437A
|
|
The analysis method of sanguisorbin I in garden burnet or product containing garden burnet
|
|
CN109956990A
|
|
A kind of method of dry Pipecuronium Bromide
|
|
CN108375644A
|
|
A kind of analysis method of neuromuscular blocking agent intermediate
|
|
CN109806232A
|
|
Tizanidine oral disintegrating tablet and preparation method thereof
|
|
CN109745323A
|
|
Azapirone compound improves the active purposes of parasympathetic nerve
|
|
CN109535150A
|
|
Phenylacetic acid Tizanidine crystal form A and its preparation method and application
|
|
CN109535149A
|
|
Methanesulfonic acid Tizanidine compound and its preparation method and application
|
|
CN109535148A
|
|
The preparation method of diazosulfide derivative
|
|
CN109535152A
|
|
Nitric acid Tizanidine crystal form A and its preparation method and application
|
|
CN109535151A
|
|
P-methyl benzenesulfonic acid Tizanidine crystal form A and its preparation method and application
|
|
CN109125436A
|
|
The heart can relaxation grain agent preparation method
|
|
CN108969498A
|
|
A kind of Tizanidine sustained release preparation and its preparation process and purposes
|
|
CN108938573A
|
|
A kind of neuromuscular blocking agent composition and its preparation method and application
|
|
CN108926564A
|
|
A kind of nondepolarizing muscle relaxant composition and its preparation method and application
|
